Ocular Therapeutix, Inc Cash Flow Statement

Cash Flow Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -14.04M-13.33M-28.21M-39.76M-44.70M-63.39M-59.98M-90.67M-69.45M-84.67M-84.88M-89.74M-165.08M
Share-based Compensation 0.24M0.48M2.64M4.64M5.96M7.32M7.48M8.76M7.53M14.98M16.96M17.82M33.11M
Gains from Sales and Divestitures 0.03M0.39M1.28M
Gains from Investment Securities 0.05M0.04M1.61M2.12M3.09M4.00M5.23M7.92M9.11M10.93M13.67M16.14M19.89M
Non-cash Items 29.46M5.90M6.66M1.22M2.63M3.79M5.00M13.28M8.57M11.07M11.42M
Cash from Operations -12.59M-12.64M-20.50M-33.74M-34.00M-50.47M-49.23M-77.58M-53.55M-65.55M-59.60M-70.23M-134.68M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.02M0.28M0.19M0.02M
Amortization of Deferred Charges 0.09M0.05M0.10M0.17M0.37M0.41M0.40M3.68M4.42M4.63M4.85M6.11M3.73M
Depreciation & Amortization (CF) 0.40M0.40M0.55M0.75M0.88M1.62M2.29M2.53M2.77M2.42M2.11M2.98M3.79M
Change in Working Capital
Change in Receivables -0.08M0.25M0.08M-0.14M0.06M-0.02M-0.03M2.35M9.70M8.88M0.19M4.85M6.21M
Change in Inventory 0.13M0.00M-0.02M0.01M0.10M0.74M0.25M0.05M0.72M0.33M0.73M
Change in Account Payables 0.14M-0.17M0.51M0.35M-0.16M0.93M-0.80M0.12M-0.45M1.80M-0.62M0.58M-0.32M
Change in Accured Expenses 0.61M-0.21M1.95M0.22M1.39M2.56M1.71M1.71M2.31M3.72M1.64M0.77M3.64M
Investing Activities
Capital Expenditures 0.20M0.39M1.26M1.78M1.92M8.25M1.89M2.24M0.84M1.19M3.71M6.09M1.29M
Sales of Property, Plant and Equipment 0.01M0.00M0.01M
Change in Acquisitions & Divestments 4.02M54.83M80.68M38.20M
Cash from Investing Activities 3.81M-0.39M-38.59M-38.57M37.07M26.95M-1.89M-2.24M-0.84M-1.19M-3.71M-6.09M-1.29M
Financing Activities
Other financing activities 0.01M0.01M3.02M0.56M0.24M0.28M5.18M
Debt Issuance and Repayment
Long-Term Debt Issuances 4.42M14.88M1.90M3.70M12.03M37.27M3.72M82.47M
Long-Term Debt Repayments 0.91M1.82M2.27M1.50M1.30M5.66M4.17M26.12M
Change in Capital Stock
Shares Issued 0.00M0.01M69.52M65.61M0.63M29.24M26.82M37.54M224.68M2.59M0.94M117.26M316.35M
Preferred Shares Issued 23.78M8.49M
Misc.
Cash from Financing Activities 27.30M6.68M78.97M65.70M0.58M32.01M68.64M75.34M228.01M2.85M1.45M169.83M332.11M
Change in Cash 18.52M-6.35M19.89M-6.61M3.65M8.49M17.52M-4.47M173.62M-63.89M-61.86M93.51M196.15M
Free Cash Flow -12.79M-13.03M-21.76M-35.52M-35.92M-58.73M-51.12M-79.82M-54.40M-66.74M-63.32M-76.32M-135.97M
Net Cash Flow 18.52M-6.35M19.89M-6.61M3.65M8.49M17.52M-4.47M173.62M-63.89M-61.86M93.51M196.15M